$8.75
+0.92%
N/A+$0.08
Healthcare
Biotechnology
NASDAQ
Negociación activa
Prothena Corporation plc, a late-stage clinical biotechnology company, focuses on discovery and development of novel therapies to treat diseases caused by protein ...
Cargando métricas clave...
© Plutux Technology Limited 2026